• Home
  • Contact Us

Soin Neuroscience

Developing treatments for chronic diseases

Developing treatments for chronic diseases
  • Home
  • About Us
  • Research & Development
    • Peripheral Arterial Disease
    • Diabetic Neuropathy
    • Additional Programs
  • Publications
    • Journal Articles
    • PAD, Diabetes & CLI Articles
    • Nitrite Articles
    • News Stories
  • Press Releases
  • Related Links
  • Contact Us
Home / Archives for Dr. Amol Soin

TheraVasc Awarded “Most Promising Life Science Technology Company” at Rice Alliance Life Science Venture Forum

August 19, 2009 By Dr. Amol Soin

Houston, TX, August, 19, 2009 – TheraVasc, LLC was named one of the most promising Life Science companies at the 8th Annual Rice Alliance for Technology & Entrepreneurship Life Science Venture Forum in Houston last week. Life Science companies showcased their new ventures for an audience of more than 400 attendees, including investors, venture capitalists, […]

Filed Under: Press Releases, Latest News

Peripheral artery disease drug developer TheraVasc raises $1.8M

December 30, 2009 By Dr. Amol Soin

TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised $1.8 million in its first round of investment capital. The funding comes from existing investors JumpStart Inc. and Portal Capital, and new investors North Coast Angel Fund, Ohio TechAngels and Dayton-based Physician Investment Group. In addition, more than a dozen individual investors […]

Filed Under: Press Releases, Latest News

Peripheral artery disease pill from TheraVasc heading to phase 2a trials

September 27, 2010 By Dr. Amol Soin

TheraVasc plans to begin enrolling patients this month in a phase 2a clinical trial of its pill designed to treat peripheral artery disease. The clinical trial, which is expected to follow 50 diabetic PAD patients for 11 weeks, could lead to big things for Cleveland-based TheraVasc. CEO Tony Giordano hopes a successful trial will position […]

Filed Under: Press Releases, Latest News

Startup Stories: A Race for Better Healing Therapies

August 6, 2011 By Dr. Amol Soin

Tony Giordano / President & CEO of TheraVasc – I am a molecular biologist with a Ph.D. from Ohio State University, and a serial entrepreneur, having started several venture-backed biotech companies in Pennsylvania. I founded TheraVasc two years ago in Cleveland, OH because I want to bring a promising new therapy from the lab to […]

Filed Under: Press Releases, Latest News

TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients

September 19, 2011 By Dr. Amol Soin

A phase 1 trial of a peripheral artery disease drug candidate from TheraVasc demonstrated safety in diabetic patients. The positive clinical trial data reported by Cleveland-based TheraVasc potentially puts the young company one step closer to a development partnership with a big drug maker or a venture round between $10 million and $20 million. The […]

Filed Under: Press Releases, Latest News

TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients

September 20, 2011 By Dr. Amol Soin

CLEVELAND, Sept. 20, 2011 /PRNewswire/ — TheraVasc (www.theravasc.com) announced the successful completion of a Phase I clinical trial of a drug, TV1001, to diabetic patients. The trial included 12 diabetic patients who each received a single dose of two different oral formulations of TV1001, an enteric coated and a non-enteric coated capsule, to determine safety […]

Filed Under: Press Releases, Latest News

Dayton-area entrepreneur on cusp of ‘billion-dollar’ product (Exclusive)

February 19, 2015 By Dr. Amol Soin

by Tristan Navera Dayton Business Journal – Febuary 4, 2015 Dr. Amol Soin is setting his sights on a new drug with immense potential for pain relief. It also has huge potential for helping to create the next billion-dollar company in the Dayton region. Soin, who is head of Centerville-based Ohio Pain Clinic, is part […]

Filed Under: Press Releases, Latest News

Hillsboro doctor develops new experimental diabetic neuropathy treatment

February 23, 2015 By Dr. Amol Soin

Highland County Press Dr. Amol Soin, Medical Director of the Ohio Pain Clinic, with an office in Hillsboro, has announced the development of a treatment for diabetic neuropathy pain. Dr. Soin and his team filed a patent last February for an investigational, non-addicting/sedating pill and filed an Investigational New Drug Application with the FDA in […]

Filed Under: Press Releases, Latest News

Dr. Amol Soin Is Interviewed On Local Dayton TV

March 10, 2015 By Dr. Amol Soin

Watch the interview of Dr. Amol Soin on Fox 45 in Dayton as he explains our new experimental diabetic pain treatment.

Filed Under: Press Releases, Latest News

Recent Releases

  • TheraVasc Awarded “Most Promising Life Science Technology Company” at Rice Alliance Life Science Venture Forum
  • Peripheral artery disease drug developer TheraVasc raises $1.8M
  • Peripheral artery disease pill from TheraVasc heading to phase 2a trials
  • Startup Stories: A Race for Better Healing Therapies
  • TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients
  • TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients

Contact Us

Amol Soin, MD, MBA
7076 Corporate Way
Dayton, OH 45458
drsoin@soinneuroscience.com


7076 Corporate Way
Dayton, OH 45458
drsoin@soinneuroscience.com

Research

  • Peripheral Arterial Disease
  • Diabetic Neuropathy
  • Additional Programs

Publications

  • Journal Articles
  • PAD, Diabetes & CLI Articles
  • Nitrite Articles
  • News Stories

Company

  • About Us
  • Press Releases
  • Related Links
  • Contact Us
Copyright © 2021 Soin Neuroscience. All Rights Reserved.

MENU
  • Home
  • About Us
  • Research & Development
    • Peripheral Arterial Disease
    • Diabetic Neuropathy
    • Additional Programs
  • Publications
    • Journal Articles
    • PAD, Diabetes & CLI Articles
    • Nitrite Articles
    • News Stories
  • Press Releases
  • Related Links
  • Contact Us